Zobrazeno 1 - 10
of 16
pro vyhledávání: '"María Sanjurjo Saez"'
Autor:
Beatriz Torroba-Sanz, Ana de Lorenzo-Pinto, Almudena Ribed-Sánchez, María Luisa Martin-Barbero, Álvaro Giménez-Manzorro, Xandra García-González, Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Saez
Publikováno v:
Farmacia Hospitalaria. 47:T26-T30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b082fe195d65d9a30c6d9ba86754201
https://doi.org/10.1016/j.farma.2022.12.013
https://doi.org/10.1016/j.farma.2022.12.013
Autor:
Beatriz Torroba-Sanz, Ana de Lorenzo-Pinto, Almudena Ribed-Sánchez, María Luisa Martin-Barbero, Álvaro Giménez-Manzorro, Xandra García-González, Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Saez
Publikováno v:
Farmacia Hospitalaria. 47:26-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aaf4e94a8c6a45371ba8a428cd6d43e
https://doi.org/10.1016/j.farma.2022.12.002
https://doi.org/10.1016/j.farma.2022.12.002
Autor:
Cristina, Villanueva-Bueno, Roberto, Collado-Borrell, Vicente, Escudero-Vilaplana, José Luis, Revuelta-Herrero, María Belén, Marzal-Alfaro, Eva, González-Haba, José Ángel, Arranz-Arija, Santiago, Osorio, Ana, Herranz-Alonso, María, Sanjurjo-Saez
Publikováno v:
Frontiers in Public Health. 10
ObjectiveThis study aims to analyze the impact of the eOncosalud app on the management and follow-up of adverse effects (AE) in patients receiving oral antineoplastic agents.Material and methodsWe performed an observational, prospective study of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cfb03fed9b640976999845e1a2c6200
https://doi.org/10.3389/fpubh.2022.978783
https://doi.org/10.3389/fpubh.2022.978783
Autor:
Judith, Abarca-Zabalía, Ma Isabel, García, Alberto, Lozano Ros, Ignacio, Marín-Jiménez, Maria L, Martínez-Ginés, Beatriz, López-Cauce, María L, Martín-Barbero, Sara, Salvador-Martín, María, Sanjurjo-Saez, Jose M, García-Domínguez, Luis A, López Fernández
Publikováno v:
International Journal of Molecular Sciences
The Th17 immune response plays a key role in autoimmune diseases such as multiple sclerosis (MS) and inflammatory bowel disease (IBD). Expression of Th17-related genes in inflamed tissues has been reported in autoimmune diseases. However, values are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a12124beafa5b11bc27e5db894bd1eb
https://pubmed.ncbi.nlm.nih.gov/31968593
https://pubmed.ncbi.nlm.nih.gov/31968593
Autor:
MBELÉN MARZAL- ALFARO, ANA DE LORENZO- PINTO, RAQUEL GARCÍA- SÁNCHEZ, MARIA ESTHER DURÁN- GARCÍA, ANTONIO MUIÑO- MIGUEZ, MARÍA SANJURJO- SAEZ
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 6, Iss 2 (2019)
Objetivo: Descrever e quantificar as discrepâncias não justificadas (DNJ) na última prescrição realizada no Serviço de Emergência (SE) e estabelecer o tempo médico de conciliação em condições práticas habituais segundo o Consenso de Conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::d07e005350ba6c500d43c03c628824f3
https://www.rbfhss.org.br/sbrafh/article/view/222
https://www.rbfhss.org.br/sbrafh/article/view/222
Autor:
Carmen Guadalupe Rodríguez González, Esther Chamorro de Vega, Sofía De la Villa Martínez, Maricela Valerio Minero, José María Gutiérrez Urbón, Álvaro Giménez Manzorro, Edurne Fernández de Gamarra Martínez, Sara Cobo Sacristán, Emilio Bouza Santiago, Ana Herranz Alonso, Patricia Muñoz García de Paredes, María Sanjurjo Sáez
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 7, Pp 1115-1122 (2023)
Background: The Study on the Clinical Use of DAPTOMycin in Spain (DAPTOMISE Study) is a national surveillance program of daptomycin use. The objectives of this study are to evaluate the current variability in daptomycin consumption across the differe
Externí odkaz:
https://doaj.org/article/d9ef8966c126497dafe2e13962bb8040
Autor:
Ana Clara Zoni, Paz Rodriguez Pérez, María Sanjurjo Saez, Rosa Pla-Mestre, Esther Durán-García, Ana Belén Jiménez-Muñoz
Publikováno v:
Open Journal of Internal Medicine. :129-134
Medication reconciliation is priority in safety. Between 54% and 67% of hospitalized patients have at least one unintended discrepancies (UDs) between pharmacological treatment of a hospital inpatient and treatment that they were previously taking at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f40d2fe6a88e647da45795b932983e9a
https://doi.org/10.4236/ojim.2013.34029
https://doi.org/10.4236/ojim.2013.34029
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 34(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b285ac82f567bb85c3a251a808f05df
https://pubmed.ncbi.nlm.nih.gov/20167525
https://pubmed.ncbi.nlm.nih.gov/20167525
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.